Can The Rally Continue?, The COVID-19 And Vaccine Effect On Stocks, And A Tough Day For Alibaba And Chinese Stocks

<p>Carl Quintanilla, Jim Cramer and David Faber discussed the road ahead for stocks and whether they can maintain their upward momentum. The anchors reacted to a new note from </p><p>Goldman Sachs Chief U.S. Equity Strategist David Kostin, who is raising his year-end S&P 500 price target to 3,700. They also explored buying strategies when it comes to value versus growth and where </p><p>COVID-19 and vaccines come into play. Also in focus: President Trump’s refusal to concede the 2020 election and what that means for the markets, Alibaba shares falling after Chinese regulators drafted anti-monopoly guidelines, and what’s driving a strong session for chip stocks.</p>